France: France: Sanofi commits another US$750m to corporate VC arm

Sanofi Ventures, the corporate VC arm of Sanofi that invests in innovators working in areas including immunology and inflammation, rare diseases, oncology, cell and gene therapy, vaccines, and digital health and data science, has announced an additional multi-year commitment from parent Sanofi, with an increase in capital to more than US$750m to the evergreen venture…

You must be a HMI Subscriber to view this content.

Subscribe Now »